Option Care Health, Inc. (NASDAQ:OPCH) Shares Acquired by Townsquare Capital LLC

Townsquare Capital LLC raised its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 6.2% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 72,675 shares of the company’s stock after purchasing an additional 4,258 shares during the period. Townsquare Capital LLC’s holdings in Option Care Health were worth $2,275,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of OPCH. Blue Trust Inc. increased its holdings in shares of Option Care Health by 14.8% during the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after buying an additional 377 shares during the last quarter. GAMMA Investing LLC increased its stake in Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after acquiring an additional 471 shares during the last quarter. Lindenwold Advisors INC raised its holdings in shares of Option Care Health by 5.4% in the 3rd quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock worth $299,000 after purchasing an additional 489 shares during the period. Trust Point Inc. lifted its stake in shares of Option Care Health by 2.6% in the 3rd quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock valued at $755,000 after purchasing an additional 622 shares in the last quarter. Finally, Nisa Investment Advisors LLC lifted its stake in shares of Option Care Health by 5.4% in the 2nd quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock valued at $376,000 after purchasing an additional 690 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Insider Buying and Selling

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of Option Care Health stock in a transaction on Friday, November 8th. The shares were purchased at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the purchase, the director now directly owns 326,334 shares of the company’s stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.64% of the company’s stock.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $23.80 on Friday. The firm has a 50-day moving average of $26.84 and a two-hundred day moving average of $28.88. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The stock has a market cap of $4.05 billion, a P/E ratio of 20.00, a PEG ratio of 2.46 and a beta of 1.32. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $34.63.

Analyst Ratings Changes

Several research analysts recently commented on OPCH shares. Truist Financial cut their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and reduced their target price for the company from $38.00 to $26.00 in a report on Thursday, October 31st. The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and lowered their price target for the company from $38.00 to $27.00 in a report on Monday, November 4th. Barrington Research reduced their price objective on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st. Finally, JMP Securities increased their target price on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $30.83.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.